Capricor Therapeutics, Inc. (CAPR) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 0 | 0 | 0 | 0 | 0 | 11.13M | 2.26M | 3.97M | 4.91M | 12.09M | 6.19M | 3.92M |
| Revenue Growth % | - | -100% | -100% | -100% | -100% | -7.92% | -63.44% | 1.38% | 64.29% | 1159.3% | 288.66% | - |
| Cost of Goods Sold | 0 | 0 | 20.36M | 22.05M | 18.92M | 14.55M | 11.81M | 12.5M | 11.1M | 9.94M | 0 | 0 |
| COGS % of Revenue | - | - | - | - | - | 130.77% | 522.09% | 314.87% | 226.23% | 82.23% | - | - |
| Gross Profit | 0 | 0 | -20.36M | -22.05M | -18.92M | -3.42M | -9.55M | -8.53M | -6.19M | 2.15M | 6.19M | 3.92M |
| Gross Margin % | - | - | - | - | - | -30.77% | -422.09% | -214.87% | -126.23% | 17.77% | 100% | 100% |
| Gross Profit Growth % | 100% | 100% | -113.27% | -158.37% | -205.38% | -259.43% | -254.32% | -317.83% | -307.39% | 123.76% | 288.66% | - |
| Operating Expenses | 36.77M | 29.16M | 5.92M | 5.67M | 6.07M | 4.27M | 3.46M | 3.06M | 4.07M | 3.43M | 13.05M | 11.66M |
| OpEx % of Revenue | - | - | - | - | - | 38.39% | 153.15% | 77% | 82.98% | 28.37% | 210.97% | 297.76% |
| Selling, General & Admin | 9.4M | 6.02M | 5.92M | 5.67M | 6.07M | 4.27M | 3.46M | 3.06M | 4.07M | 3.43M | 2.91M | 2.75M |
| SG&A % of Revenue | - | - | - | - | - | 38.39% | 153.15% | 77% | 82.98% | 28.37% | 47.01% | 70.2% |
| Research & Development | 27.38M | 23.13M | 20.36M | 22.05M | 18.92M | 14.55M | 11.81M | 12.5M | 11.1M | 9.94M | 10.03M | 8.82M |
| R&D % of Revenue | - | - | - | - | - | 130.77% | 522.09% | 314.87% | 226.23% | 82.23% | 162.13% | 225.08% |
| Other Operating Expenses | 0 | 0 | -1000K | -1000K | -1000K | -1000K | -1000K | -1000K | -1000K | -1000K | 113.68K | 97.3K |
| Operating Income | -36.77M | -29.16M | -26.28M | -27.72M | -24.98M | -7.7M | -13.01M | -11.59M | -10.27M | -1.28M | -6.86M | -7.75M |
| Operating Margin % | - | - | - | - | - | -69.16% | -575.24% | -291.86% | -209.21% | -10.6% | -110.97% | -197.76% |
| Operating Income Growth % | -47.19% | -278.78% | -102.03% | -139.14% | -143.36% | -500.79% | -89.52% | -49.62% | -25.43% | 84.12% | -5.97% | -5.81% |
| EBITDA | -36.77M | -29.16M | -25.79M | -27.23M | -24.58M | -7.32M | -12.65M | -11.23M | -9.93M | -973.68K | -6.59M | -7.49M |
| EBITDA Margin % | - | - | - | - | - | -65.78% | -559.27% | -282.88% | -202.46% | -8.05% | -106.5% | -191.26% |
| EBITDA Growth % | -49.62% | -298.21% | -103.89% | -142.41% | -147.4% | -652% | -91.99% | -49.94% | -24.89% | 87.64% | -3.9% | -3.92% |
| D&A (Non-Cash Add-back) | 0 | 0 | 494.73K | 486.28K | 405.45K | 375.7K | 361.17K | 356.94K | 331.41K | 307.61K | 276.47K | 254.7K |
| EBIT | -36.77M | -29.16M | -24.57M | -27.72M | -24.98M | -7.7M | -13.01M | -11.59M | -10.27M | -1.28M | -6.86M | -7.75M |
| Net Interest Income | 2.9M | -1.02M | 1.71M | 1.79M | 729.54K | 686.57K | 453.15K | 591.44K | 471.83K | 233.93K | 0 | 0 |
| Interest Income | 2.9M | 2.02M | 1.71M | 1.79M | 729.54K | 686.57K | 453.15K | 591.44K | 471.83K | 233.93K | 0 | 0 |
| Interest Expense | 0 | 3.05M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Income/Expense | 2.83M | -1.01M | 1.71M | 1.81M | 591.35K | 581.24K | 453.15K | 591.44K | 471.83K | 519.2K | 473.99K | 380.68K |
| Pretax Income | -33.94M | -30.17M | -24.57M | -25.91M | -24.39M | -7.12M | -12.56M | -11M | -9.79M | -762.09K | -6.39M | -7.37M |
| Pretax Margin % | - | - | - | - | - | -63.94% | -555.2% | -276.97% | -199.6% | -6.3% | -103.31% | -188.04% |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | -33.94M | -30.17M | -24.57M | -25.91M | -24.39M | -7.12M | -12.56M | -11M | -9.79M | -762.09K | -6.39M | -7.37M |
| Net Margin % | - | - | - | - | - | -63.94% | -555.2% | -276.97% | -199.6% | -6.3% | -103.31% | -188.04% |
| Net Income Growth % | -39.15% | -323.95% | -95.68% | -135.56% | -149.04% | -833.83% | -96.49% | -49.32% | -26.08% | 90.13% | -0.31% | -3.62% |
| Net Income (Continuing) | -33.94M | -30.17M | -24.57M | -25.91M | -24.39M | -7.12M | -12.56M | -11M | -9.79M | -762.09K | -6.39M | -7.37M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.59 | -0.62 | -0.54 | -0.57 | -0.53 | -0.16 | -0.38 | -0.35 | -0.31 | -0.02 | -0.25 | -0.29 |
| EPS Growth % | -11.32% | -287.5% | -42.11% | -62.86% | -70.97% | -542.57% | -52% | -20.69% | 0% | 91.97% | 3.85% | 0% |
| EPS (Basic) | -0.59 | -0.62 | -0.54 | -0.57 | -0.53 | -0.16 | -0.38 | -0.35 | -0.31 | -0.02 | -0.25 | -0.29 |
| Diluted Shares Outstanding | 57.43M | 48.85M | 45.72M | 45.71M | 45.64M | 35.22M | 33.09M | 31.84M | 31.36M | 26.78M | 25.82M | 25.34M |
| Basic Shares Outstanding | 57.43M | 48.85M | 45.72M | 45.71M | 45.64M | 35.22M | 33.09M | 31.84M | 31.36M | 26.78M | 25.82M | 25.34M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - |